Evidence 1
Activity
Activity
50% Hemolysis
Toxicity
>800 µg/mL
Hemolytic
Cytotoxic
50% Hemolysis | >800 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity | Peptides | 2009